I wrote before about a simple test to predict heart attack being offered by Rapha Health Institute, a medical clinic specializing in anti-aging and alternative medicine in Greenbelt 5. The center is headed by world renowned cardiologist Dr. Cris Enriquez.
I am happy to report that five readers of this blog will be chosen to avail of free CardioVision Diagnostic Test on October 15, 2011. The test, with interpretation of the results and consultation at the clinic, usually costs P2500.The test is deemed essential if you want to know whether you’re vulnerable to a heart attack within the next ten years.
Here’s how to join the promo:
1. Like the Rapha Health Institute and Ajay’s Writings on the Wall pages on Facebook
2. Tweet about the cardiovision test at Rapha using this URL link
3. After you have done Steps 1 and 2, email me at annalyn(dot)net(at)hotmail.com with your name and link to your tweet
Five winners will be drawn through random raffle at random.org by October 10, 2011.
Winners must be free to take the test on October 15 (Saturday) from 12noon to 6pm at the Rapha Health Institute, 4th floor, Greenbelt 5, Makati City.
CardioVision is an FDA-approved instrument that has been used in the United States, Japan and many other countries for many years. It is a non-invasive procedure that determines the amount of rigidity of arteries that produce major catastrophic vascular event. The test itself only lasts for several minutes. It is characterized by several blood pressure tests to determine the risks for arterial blockage. You don’t have to be suffering from cardiovascular disease in order to take this test, as it can be useful to screen you for heart disease in the future.
The lucky patients who avail of FREE CardioVision will be given a 20% discount if they opt to buy the package of 10 for the IV Therapies (Chelation, Hydrogen Peroxide, Diabetes Protocol, Vitamin Infusion, etc). Senior Citizens will get additional 5% discount if they opt to buy the package.
NooBite says
I am running a contest. Maybe you could join.